Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates – authors' reply
Alimentary Pharmacology & Therapeutics · 2023
DOI: 10.1111/apt.17423 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, 2023. Written by Yao Tong and 2 co-authors. Institution: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Radiofrequency Ablation, Catheter Ablation. Cited 1 times so far (Crossref); 8 references.
Abstract (original language)
LINKED CONTENT This article is linked to Tong et al papers. To view these articles, visit https://doi.org/10.1111/apt.17263 and https://doi.org/10.1111/apt.17409
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
ORCID profiles: De-Hua Chang, Yu-Dong Xiao
Cite
APA
Tong, Y., Chang, D. H., & Xiao, Y. D. (2023). Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates – authors' reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17423
Vancouver
Tong Y, Chang DH, Xiao YD. Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates – authors' reply. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17423
BibTeX
@article{Tong2023,
author = {Tong, Yao and Chang, De-Hua and Xiao, Yu-Dong},
title = {Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates – authors' reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
doi = {10.1111/apt.17423}
}
EUVIMED